Toronto, Ontario--(Newsfile Corp. - July 29, 2022) - Optimind Pharma Corp. ("Optimind" or the "Company") announces the successful closing of its previously announced reverse takeover ("RTO") of Loon ...
Optimind looks to accelerate the adoption of the MindSetting(TM) TRIP Protocol for ketamine-assisted therapy and other psychedelic enhanced psychotherapy modalities. Toronto, Ontario--(Newsfile Corp. ...
Redefining Recruitment with AI, Data, and Human Intelligence Monjin is advancing talent acquisition by uniquely blending advanced artificial intelligence, big data, and a global network of expert ...
TORONTO, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") is pleased to announce that it has entered into an acquisition agreement dated October 12 ...
AUSTIN, Texas--(BUSINESS WIRE)--OptiMind, the breakthrough premium nootropic from direct to consumer health company AlternaScript, is improving brain function for thousands of dedicated consumers with ...
TORONTO, ON / ACCESSWIRE / January 26, 2024 / Optimind Pharma Corp. (CSE:OMND) (the "Optimind" or the "Company") advises that it has reached agreement with holders of principal amount $303,750 ...
Toronto, Ontario--(Newsfile Corp. - July 3, 2024) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") announces a proposed private placement. The Company intends to issue up to ...
to be able to take the mind, our brain’s ability, to another level. OptiMind’s ingredients were grown ethically, with a high level of scrutiny for quality control, and tested through clinical studies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results